HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc. The company is also involved in e-commerce, investment, and financing activities. Additionally, it develops biological drugs with MoA to infectious diseases. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.
Metrics to compare | 028300 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship028300PeersSector | |
|---|---|---|---|---|
P/E Ratio | −34.6x | −4.2x | −0.6x | |
PEG Ratio | 2.62 | 0.12 | 0.00 | |
Price/Book | 20.2x | 1.8x | 2.6x | |
Price / LTM Sales | 94.3x | 3.1x | 3.4x | |
Upside (Analyst Target) | - | 49.1% | 41.5% | |
Fair Value Upside | Unlock | 5.3% | 4.4% | Unlock |